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Challenges of centralizing cancer care in the US
Dear Editor,
Cancer is a major global public health problem and is the second 
leading cause of death in the United States (US) [1]. Unfortunately, 
despite tremendous medical advances in early diagnosis and treatment 
of several cancer types, socioeconomic inequalities persist in cancer 
survival. Cancer incidence and death rates vary considerably between 
racial and ethnic groups [1]. Economic status is also a determinant for 
appropriate cancer care. Within the four cancer types for which 
screening is widely recommended (colorectal, breast, cervix, and 
prostate), the proportion of cases diagnosed at advanced stage is higher 
in high-poverty census groups [2].
Centralizing cancer care has shown significant benefits in other 
countries. The Netherlands is a remarkable example of centralization of 
cancer treatment. The Dutch Cancer Society formed a “Quality of 
Cancer Care Taskforce” in 2007, and concluded that variation in quality 
of care for cancer patients in the Netherlands was dependent on 
structural characteristics of cancer care hospitals such as diagnostic and 
procedural volume, and academic or teaching status. The centralization 
of cancer care in The Netherlands showed promising results, with a 
reduction in postoperative morbidity and mortality, and improved long-
term survival [3].
Equity in access would contribute greatly to bridging the gap pro-
duced by social determinants of health care. In a large country like the 
US, one of the concerns with centralization is that it may increase 
health care disparities in undeserved patients that cannot travel, or who 
may wish to seek care close to home. Interestingly, this concern might 
not be well founded. Our study group recently found that a process of 
spontaneous centralization of esophageal cancer surgery occurred in 
the US, and the overall mortality rate after esophagectomy dropped 
from 10.0% in 2000, to 3.5% in 2011. The reduction in mortality was 
higher among low household income patients, and showed no differ-
ences between non-Hispanic white patients and other races patients, or 
between private primary insurance patients and public primary in-
surance patients [4].
Unfortunately, with the lack of uniform prescriptive guidelines or 
volume standards implementation, the attainment of centralization of 
cancer care is currently aspirational in the US. This is attributable to 
several factors:
(1) The US health care system is fragmented, complex, and comprises a
variety of public and private institutions that handle payment, in-
surance, and delivery functions and exists within a milieu of un-
certainty in the current political climate.
(2) Many patients prefer to seek definitive cancer care near home at
local community hospital, rather than in an unknown center far
from their support networks.
(3) The United States is a very large country. For instance, the entire
country of Netherlands is smaller than many US states. Geographic
variability in location of specialized regional centers will differ
adding to the complexity of achieving uniformity in patient access.
(4) With variations in health care system networks across the country,
determining centers of excellence designation and steering patient
referrals to such centers is intricate.
(5) The financial implications of patient referral to high volume centers
may be a disincentive to centralization of care. Health care systems
encourage referral to in-system providers in order to maintain
market share.
(6) Cancer care requires a high level of multidisciplinary treatment,
sufficient medical staff, and specialized treatment facilities.
Specialized hospitals and providers would need to be able to
manage the influx of patients referrals, and ensure that those fa-
cilities can accommodate the high volume of patients.
The development of regional cancer care networks is a reasonable
strategy. The University of Pittsburg Medical Center (UPMC) estab-
lished one of the largest oncology networks in the US. The UPMC
Cancer Center includes a regional hub and satellite facilities, allowing
for coordination of patient care across facilities and physician groups.
Through this system, patients benefit from improved access at satellite
locations and facilitated referrals for further treatment at the cen-
tralized cancer center [5].
Regional cancer networks, with central core facilities tele-mentoring
and tele-monitoring remote centers could overcome geographic bar-
riers. First, patients would benefit from community-based screening
centers. Second, liquid tumors and many solid tumors could be effec-
tively treated in these peripheral centers if properly monitored by the
central facility. Third, patients could be promptly referred for complex
surgical procedures of certain solid tumors. Even if these specialized
treatment facilities are located in areas where travel time is longer for
patients, the inconveniences of longer travel times may be mitigated by
improved cancer outcomes.
In conclusion, at the present time many patients fail to obtain high
quality cancer care. As spontaneous centralization of care is already
occurring for some type of cancers in the US, showing better outcomes,
we feel that the process could be further enhanced by clear guidelines
and regulation.
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